Since 1967, Fermilab has worked to answer these and other fundamental questions and enhance our understanding of everything we see around us. As the United States' premier particle physics laboratory, we work on the world's most advanced particle accelerators and dig down to the smallest building blocks of matter.
So, survival rate and life expectancy for stage 4 prostate cancer cannot be favorable. âº The five-year relative survival rate for prostate cancer that has spread to distant organs is 28%. This means about 28% of the patients with stage 4 prostate cancer will live for five years.
Colorectal cancer is divided into four stages, with Stage 4 having the worst prognosis (outlook). The five year survival rates (the percentage of people surviving the disease for 5 years after treatment), listed by stage, are as follows: Stage 1- 74% (and often higher if there are favorable features) Stage 2- 37% to 67%. Stage 3- 30% to 50%.